Skip to main content
SpringerLink
Log in

Clinical Implications of Head and Neck Cancer

  • Chapter
  • First Online:
Imaging in Clinical Oncology

  • 1637 Accesses

Abstract

The survival of tobacco-associated Head and Neck Squamous Cell Carcinoma (HNSCC) has not substantially changed over the past 30 years. Novel agents and strategies are being tested in several clinical trials. Quantitative imaging using computed tomography, magnetic resonance imaging, and positron emission tomography modalities plays a pivotal role in the design of clinical trials addressing molecularly targeted therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kurland BF, Gerstner ER, Mountz JM et al (2012) Promise and pitfalls of quantitative imaging in oncology clinical trials. Magn Reson Imaging 30:1301–1312

    Article  Google Scholar 

  2. Ferris RL, Blumenschein G Jr, Fayette J et al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375(19):1856–1867

    Article  Google Scholar 

  3. Seiwert TY, Burtness B, Mehra R et al (2016) Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. Lancet Oncol 17(7):956–965

    Article  CAS  Google Scholar 

  4. 2010 ACSCFaFACS

    Google Scholar 

  5. Cabanillas ME, Hu MI, Durand JB, Busaidy NL (2011) Challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer. J Thyroid Res 2011:985780

    Article  Google Scholar 

  6. Bible KC, Suman VJ, Molina JR et al (2010) Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol 11:962–972

    Article  CAS  Google Scholar 

  7. Carr LL, Mankoff DA, Goulart BH et al (2010) Phase II study of daily sunitinib in FDG-PET-positive, iodine- refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation. Clin Cancer Res 16:5260–5268

    Article  CAS  Google Scholar 

  8. Kloos RT, Ringel MD, Knopp MV et al (2009) Phase II trial of sorafenib in metastatic thyroid cancer. J Clin Oncol 27:1675–1684

    Article  CAS  Google Scholar 

  9. Wells SA Jr, Gosnell JE, Gagel RF et al (2010) Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol 28:767–772

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2nd Department of Interna Medicine, Section of Medical Oncology, Attikon University Hospital, Athens, Greece

    Panagiota Economopoulou & Amanda K. Psyrri

Authors
  1. Panagiota Economopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda K. Psyrri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amanda K. Psyrri .

Editor information

Editors and Affiliations

  1. School of Medicine, National and Kapodistrian, University of Athens, Athens, Greece

    Athanasios D. Gouliamos

  2. Imaging Department, Hygeia and Mitera Hospitals, Athens, Greece

    John A. Andreou

  3. Medical Oncologist, Head, Medical Oncology Department, Hygeia Hospital, Athens, Greece

    Paris A. Kosmidis

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Economopoulou, P., Psyrri, A.K. (2018). Clinical Implications of Head and Neck Cancer. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-68873-2_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-68872-5

  • Online ISBN: 978-3-319-68873-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation